Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
This study has been terminated.
Study NCT01088763 Information provided by National Cancer Institute (NCI)
First Received on March 16, 2010. Last Updated on May 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Childhood Choroid Plexus Tumor
Childhood Craniopharyngioma
Childhood Ependymoblastoma
Childhood Grade I Meningioma
Childhood Grade II Meningioma
Childhood Grade III Meningioma
Childhood Infratentorial Ependymoma
Childhood Medulloepithelioma
Childhood Mixed Glioma
Childhood Oligodendroglioma
Childhood Supratentorial Ependymoma
Gonadotroph Adenoma
Pituitary Basophilic Adenoma
Pituitary Chromophobe Adenoma
Pituitary Eosinophilic Adenoma
Prolactin Secreting Adenoma
Recurrent Childhood Ependymoma
Recurrent Childhood Medulloblastoma
Recurrent Childhood Pineoblastoma
Recurrent Pituitary Tumor
TSH Secreting Adenoma
Additional conditions recognized in this trial
Adamantinoma
Adenoma
Adenoma, Acidophil
Adenoma, Basophil
Adenoma, Chromophobe
Astrocytoma
Carcinoma, Embryonal
Central Nervous System Neoplasms
Choriocarcinoma
Choroid Plexus Neoplasms
Craniopharyngioma
Endodermal Sinus Tumor
Ependymoma
Germinoma
Glioma
Hodgkin Disease
Leukemia
Leukemia, Large Granular Lymphocytic
Leukemia, Lymphoid
Leukemia, T-Cell
Lymphoma
Lymphoma, Extranodal NK-T-Cell
Lymphoma, Large-Cell, Anaplastic
Lymphoma, Non-Hodgkin
Lymphomatoid Granulomatosis
Medulloblastoma
Meningioma
Neoplasms
Neoplasms, Germ Cell and Embryonal
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Oligodendroglioma
Optic Nerve Glioma
Pinealoma
Pituitary Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prolactinoma
Rhabdoid Tumor
Spinal Cord Neoplasms
Teratoma
More general conditions related to this trial
Adenocarcinoma
Bone Diseases
Bone Neoplasms
Brain Diseases
Brain Neoplasms
Carcinoma
Central Nervous System Diseases
Cerebral Ventricle Neoplasms
Cranial Nerve Diseases
Cranial Nerve Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Eye Diseases
Gestational Trophoblastic Neoplasms
Hypothalamic Diseases
Hypothalamic Neoplasms
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoma, T-Cell
Lymphoproliferative Disorders
Meningeal Neoplasms
Mesonephroma
Musculoskeletal Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplasms, Vascular Tissue
Nervous System Diseases
Nervous System Neoplasms
Neuroendocrine Tumors
Optic Nerve Diseases
Optic Nerve Neoplasms
Peripheral Nervous System Neoplasms
Pituitary Diseases
Precancerous Conditions
Pregnancy Complications
Pregnancy Complications, Neoplastic
Spinal Cord Diseases
Supratentorial Neoplasms
Trophoblastic Neoplasms
Interventions listed in this trial
pharmacological study
dexamethasone
Additional drug interventions recognized in this trial
BB 1101
Dexamethasone 21-phosphate
Dexamethasone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
